Insideraktier | 156 426 909 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
UNIVERSAL BIOSENSORS INC insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i UBI / UNIVERSAL BIOSENSORS INC. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i UBI / UNIVERSAL BIOSENSORS INC. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-11 | 3 | Mullin Peter George Mullin Family Superannuation Fund | UBI | Common Stock | I | 1 519 261 | ||||||||
2025-02-11 | 3 | Mullin Peter George Mullin Family Trust | UBI | Common Stock | I | 577 000 | ||||||||
2025-02-11 | 3 | Mullin Peter George | UBI | Common Stock | D | 444 424 | ||||||||
2024-05-28 | 2024-05-27 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 0,1100 | 275 000 | 30 | 1 561 217 | ||||
2024-05-28 | 2024-05-27 | 4 | McLean Graham A | UBI | Common Stock | I | 0,1100 | 275 000 | 30 | 1 080 116 | ||||
2024-05-28 | 2024-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1100 | 1 421 293 | 156 | 87 509 318 | ||||
2024-05-03 | 2024-05-01 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,1500 | 217 182 | 33 | 970 802 | ||||
2024-05-03 | 2024-05-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1500 | 29 289 424 | 4 393 | 86 088 025 | ||||
2024-05-03 | 2024-05-01 | 4 | McLean Graham A | UBI | Common Stock | I | 0,1500 | 180 116 | 27 | 805 116 | ||||
2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart By superannuation fund | UBI | Common Stock | I | 0,1500 | 30 000 | 4 | 394 666 | ||||
2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart | UBI | Common Stock | D | 0,1500 | 23 055 | 3 | 103 055 | ||||
2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 0,1500 | 10 000 | 2 | 1 286 217 | ||||
2024-05-03 | 2024-05-01 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,1500 | 99 077 | 15 | 442 873 | ||||
2024-05-03 | 2024-03-25 | 4 | Sharman John Stewart | UBI | Common Stock | D | −1 000 000 | 80 000 | ||||||
2024-05-03 | 2024-03-25 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 1 000 000 | 1 276 217 | ||||||
2024-03-26 | 2024-03-25 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2000 | 1 000 000 | 200 | 56 798 601 | ||||
2024-03-25 | 2024-03-25 | 4 | Sharman John Stewart | UBI | Common Stock | D | 0,2000 | 1 364 666 | 273 | 1 444 666 | ||||
2023-12-11 | 2023-12-11 | 4 | McLean Graham A Stock acquired by Milray Enterprises Pty Ltd ATF Graham McLean Family Trust | UBI | Common Stock | I | 0,1987 | 75 000 | 15 | 625 000 | ||||
2023-09-13 | 2023-09-11 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2200 | 100 000 | 22 | 753 620 | ||||
2023-08-21 | 2023-06-30 | 4 | Hoey David L | UBI | Common Stock | D | 0,1679 | 95 983 | 16 | 662 397 | ||||
2023-03-15 | 2023-03-14 | 4 | McLean Graham A | UBI | Common Stock | I | 0,2500 | 150 000 | 38 | 550 000 | ||||
2023-01-03 | 2023-01-01 | 4 | Balak Salesh | UBI | Common Stock | D | 50 000 | 388 558 | ||||||
2023-01-03 | 2023-01-01 | 4 | Sharman John Stewart | UBI | Common Stock | D | 50 000 | 80 000 | ||||||
2022-12-13 | 2022-12-12 | 4 | McLean Graham A | UBI | Common Stock | I | 0,2300 | 200 000 | 46 | 400 000 | ||||
2022-11-16 | 2022-11-16 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2400 | 17 848 | 4 | 653 620 | ||||
2022-11-16 | 2022-11-15 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2400 | 82 152 | 20 | 635 772 | ||||
2022-11-16 | 2022-11-11 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2500 | 50 000 | 12 | 553 620 | ||||
2022-08-18 | 2022-08-17 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2800 | 200 000 | 56 | 503 620 | ||||
2022-06-21 | 2022-05-27 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,7700 | 43 796 | 34 | 343 796 | ||||
2022-06-15 | 2022-06-09 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,3800 | 25 000 | 10 | 303 620 | ||||
2022-06-01 | 2022-06-01 | 4 | McLean Graham A | UBI | Common Stock | I | 0,4600 | 96 613 | 44 | 200 000 | ||||
2022-06-01 | 2022-05-31 | 4 | McLean Graham A | UBI | Common Stock | I | 0,4600 | 3 387 | 2 | 103 387 | ||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $1.00) | I | 1 920 000 | 1 920 000 | ||||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $0.92) | I | 1 920 000 | 1 920 000 | ||||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $0.20) | I | 0,5700 | 1 000 000 | 570 | 1 000 000 | ||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,4350 | 1 280 000 | 557 | 55 798 601 | ||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7700 | 25 893 617 | 19 938 | 54 518 601 | ||||
2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,7700 | 10 000 | 8 | 278 620 | ||||
2022-05-31 | 2022-05-24 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,4800 | 48 620 | 23 | 268 620 | ||||
2022-05-31 | 2022-05-27 | 4 | Sharman John Stewart By wife | UBI | Stock Option (Right to Buy) | I | 0,20 | 0,5700 | −1 000 000 | −570 | 0 | |||
2022-05-27 | 2022-05-27 | 4 | Balak Salesh | UBI | Common Stock | D | 0,7700 | 2 000 | 2 | 338 558 | ||||
2022-05-13 | 2022-05-12 | 4 | McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member | UBI | Common Stock | I | 0,5000 | 64 962 | 32 | 100 000 | ||||
2022-05-13 | 2022-05-11 | 4 | McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member | UBI | Common Stock | I | 0,5000 | 35 038 | 18 | 35 038 | ||||
2022-02-28 | 2022-02-24 | 4 | Balak Salesh | UBI | Common Stock | D | 30 000 | 336 558 | ||||||
2022-02-28 | 2022-02-24 | 4 | Sharman John Stewart | UBI | Common Stock | D | 30 000 | 30 000 | ||||||
2021-11-05 | 2021-11-05 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7490 | 329 613 | 247 | 28 624 984 | ||||
2021-11-05 | 2021-11-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7490 | 152 638 | 114 | 28 295 371 | ||||
2021-11-05 | 2021-11-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7300 | 896 506 | 654 | 28 142 733 | ||||
2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | −40 000 | 0 | |||||
2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Performance Rights | D | 250 000 | 250 000 | ||||||
2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Performance Rights | D | 500 000 | 500 000 | ||||||
2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Common Stock | D | 40 000 | 306 558 | ||||||
2021-09-14 | 2021-08-19 | 4 | Sharman John Stewart | UBI | Performance Rights | D | 1 250 000 | 1 250 000 | ||||||
2021-09-14 | 2021-08-19 | 4 | Sharman John Stewart | UBI | Performance Rights | D | 2 500 000 | 2 500 000 | ||||||
2021-09-14 | 2020-03-24 | 4 | Sharman John Stewart By wife | UBI | Stock Option (Right to Buy) | I | 0,20 | 1 000 000 | 1 000 000 | |||||
2021-09-14 | 2020-03-24 | 4 | Sharman John Stewart | UBI | Stock Option (Right to Buy) | D | 0,20 | −1 000 000 | 1 364 666 | |||||
2021-01-11 | 2021-01-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | −12 559 109 | 27 246 227 | ||||||
2020-12-23 | 2020-12-11 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | −40 000 | 0 | |||||
2020-12-23 | 2020-12-11 | 4 | Balak Salesh | UBI | Common Stock | D | 40 000 | 266 558 | ||||||
2020-11-03 | 2020-11-02 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,3100 | 200 000 | 62 | 300 000 | ||||
2020-09-15 | 2020-09-15 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3400 | 784 687 | 267 | 39 805 336 | ||||
2020-09-15 | 2020-09-14 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3300 | 80 178 | 26 | 39 020 649 | ||||
2020-09-15 | 2020-09-10 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3250 | 135 135 | 44 | 38 940 471 | ||||
2020-09-09 | 2020-09-01 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,30 | 500 000 | 500 000 | |||||
2020-09-08 | 2020-09-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3250 | 322 315 | 105 | 38 805 336 | ||||
2020-09-08 | 2020-09-04 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3040 | 284 962 | 87 | 38 483 021 | ||||
2020-09-08 | 2020-09-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3210 | 100 000 | 32 | 38 198 059 | ||||
2020-07-30 | 2020-07-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2500 | 730 999 | 183 | 12 559 109 | ||||
2020-07-30 | 2020-07-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2500 | 1 461 998 | 365 | 38 098 059 | ||||
2020-07-09 | 2020-07-07 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2200 | −23 820 765 | −5 241 | 0 | ||||
2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552 434 | ||||||||
2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552 434 | ||||||||
2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552 434 | ||||||||
2019-12-02 | 2019-12-02 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2000 | 119 519 | 24 | 36 636 061 | ||||
2019-12-02 | 2019-11-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2000 | 1 885 217 | 377 | 36 516 542 | ||||
2019-12-02 | 2019-11-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1910 | 214 783 | 41 | 34 631 325 | ||||
2019-11-25 | 2019-11-12 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | −25 000 | 0 | |||||
2019-11-25 | 2019-11-12 | 4 | Balak Salesh | UBI | Common Stock | D | 25 000 | 226 558 | ||||||
2019-11-18 | 2019-11-15 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1900 | 36 500 | 7 | 34 416 542 | ||||
2019-11-18 | 2019-11-13 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1860 | 669 597 | 125 | 34 380 042 | ||||
2019-11-18 | 2019-11-01 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,1800 | −3 439 866 | −619 | 18 442 469 | ||||
2019-09-12 | 2019-09-12 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,1900 | 80 000 | 15 | 21 882 335 | ||||
2019-09-12 | 2019-09-11 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,1900 | 1 710 683 | 325 | 21 802 335 | ||||
2019-09-12 | 2019-09-12 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1900 | 80 000 | 15 | 33 710 445 | ||||
2019-09-12 | 2019-09-11 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1900 | 1 710 683 | 325 | 33 630 445 | ||||
2019-07-09 | 2019-05-29 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | −73 334 | 0 | |||||
2019-07-09 | 2019-05-29 | 4 | Balak Salesh | UBI | Common Stock | D | 73 334 | 201 558 | ||||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | −105 000 | 0 | |||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | −25 000 | 0 | |||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | −40 000 | 0 | |||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | −40 000 | 0 | |||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 40 000 | 291 837 | ||||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 40 000 | 291 837 | ||||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 25 000 | 211 837 | ||||||
2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 105 000 | 186 837 | ||||||
2019-03-06 | 2019-03-05 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2100 | 176 151 | 37 | 23 820 765 | ||||
2019-03-05 | 2019-03-01 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2100 | 100 000 | 21 | 23 644 614 | ||||
2019-01-14 | 2018-12-14 | 4 | Balak Salesh | UBI | Common Stock | D | 4 166 | 128 224 | ||||||
2019-01-14 | 2018-11-16 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | −25 000 | 0 | |||||
2019-01-14 | 2018-11-16 | 4 | Balak Salesh | UBI | Common Stock | D | 25 000 | 124 058 | ||||||
2019-01-14 | 2018-11-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | −25 000 | 0 | |||||
2019-01-14 | 2018-11-16 | 4 | Oates Adrian | UBI | Common Stock | D | 25 000 | 81 837 | ||||||
2019-01-14 | 2018-12-14 | 4 | Legleiter Rick L | UBI | Common Stock | D | 4 166 | 162 853 | ||||||
2018-12-06 | 2018-12-04 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2100 | 1 500 000 | 315 | 23 544 614 | ||||
2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43 889 228 | ||||||||
2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43 889 228 | ||||||||
2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43 889 228 | ||||||||
2018-11-05 | 2018-10-11 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2300 | 100 000 | 23 | 22 044 614 | ||||
2018-05-11 | 2018-05-09 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2400 | 66 584 | 16 | 31 915 182 | ||||
2018-05-11 | 2018-05-09 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2400 | 66 584 | 16 | 11 823 530 | ||||
2018-05-08 | 2018-05-04 | 4 | Legleiter Rick L | UBI | Common Stock | D | 0,2585 | 158 687 | 41 | 158 687 | ||||
2018-05-07 | 2018-05-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2320 | 198 640 | 46 | 31 848 598 | ||||
2018-05-07 | 2018-05-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2280 | 124 305 | 28 | 31 649 958 | ||||
2018-05-07 | 2018-05-07 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2320 | 198 640 | 46 | 11 756 946 | ||||
2018-05-07 | 2018-05-03 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2280 | 124 305 | 28 | 11 558 306 | ||||
2018-03-19 | 2018-03-15 | 4 | Hoey David L | UBI | Common Stock | D | 0,2051 | 100 000 | 21 | 566 414 | ||||
2018-02-05 | 2018-02-01 | 4 | Hoey David L | UBI | Common Stock | D | 0,2300 | 116 414 | 27 | 466 414 | ||||
2017-12-29 | 2017-12-29 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3000 | 750 318 | 225 | 11 434 001 | ||||
2017-12-29 | 2017-12-28 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2940 | 50 374 | 15 | 10 683 683 | ||||
2017-12-29 | 2017-12-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2890 | 56 245 | 16 | 10 633 309 | ||||
2017-12-29 | 2017-12-22 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2690 | 33 613 | 9 | 10 577 064 | ||||
2017-12-29 | 2017-12-29 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,3000 | 2 250 953 | 675 | 20 091 652 | ||||
2017-12-29 | 2017-12-28 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,2940 | 151 124 | 44 | 17 840 699 | ||||
2017-12-29 | 2017-12-27 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,2890 | 168 737 | 49 | 17 689 575 | ||||
2017-12-29 | 2017-12-22 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,2690 | 100 838 | 27 | 17 520 838 | ||||
2017-12-29 | 2017-12-29 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3000 | 3 001 271 | 900 | 31 525 653 | ||||
2017-12-29 | 2017-12-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2940 | 201 498 | 59 | 28 524 382 | ||||
2017-12-29 | 2017-12-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2890 | 224 982 | 65 | 28 322 884 | ||||
2017-12-29 | 2017-12-22 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2690 | 134 451 | 36 | 28 097 902 | ||||
2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0,80 | 3 300 000 | 3 300 000 | |||||
2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0,60 | 2 700 000 | 2 700 000 | |||||
2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0,50 | 1 600 000 | 1 600 000 | |||||
2017-10-26 | 2017-10-24 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | −16 667 | 0 | |||||
2017-10-26 | 2017-10-24 | 4 | Balak Salesh | UBI | Common Stock | D | 16 667 | 99 058 | ||||||
2017-10-26 | 2017-10-24 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy | D | 0,00 | −25 000 | 0 | |||||
2017-10-26 | 2017-10-24 | 4 | Chambers Garry | UBI | Common Stock | D | 25 000 | 2 275 594 | ||||||
2017-10-26 | 2017-10-24 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | −25 000 | 0 | |||||
2017-10-26 | 2017-10-24 | 4 | Hodges Alastair | UBI | Common Stock | D | 25 000 | 2 871 615 | ||||||
2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | −16 667 | 0 | |||||
2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | −25 000 | 0 | |||||
2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Common Stock | D | 41 667 | 56 837 | ||||||
2017-03-27 | 2016-12-28 | 4 | Hodges Alastair | UBI | Restricted Shares of Common Stock | D | 3 030 | 2 846 615 | ||||||
2017-03-27 | 2016-12-28 | 4 | Oates Adrian | UBI | Restricted Shares of Common Stock | D | 3 030 | 15 170 | ||||||
2017-03-27 | 2016-12-28 | 4 | Chambers Garry | UBI | Restricted Shares of Common Stock | D | 3 030 | 2 250 594 | ||||||
2017-03-27 | 2016-12-28 | 4 | Balak Salesh | UBI | Restricted Shares of Common Stock | D | 3 030 | 82 391 | ||||||
2017-03-01 | 2017-03-01 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3800 | 32 988 | 13 | 10 543 451 | ||||
2017-03-01 | 2017-02-28 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3850 | 247 001 | 95 | 10 510 463 | ||||
2017-03-01 | 2017-02-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3820 | 402 924 | 154 | 10 263 462 | ||||
2017-03-01 | 2017-03-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3800 | 32 988 | 13 | 27 963 451 | ||||
2017-03-01 | 2017-02-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3850 | 247 001 | 95 | 27 930 463 | ||||
2017-03-01 | 2017-02-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3820 | 402 924 | 154 | 27 683 462 | ||||
2017-02-17 | 2017-02-17 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,3650 | 65 000 | 24 | 100 000 | ||||
2017-02-17 | 2017-02-14 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,3350 | 35 000 | 12 | 35 000 | ||||
2017-02-16 | 2017-02-14 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3400 | 7 782 | 3 | 9 860 538 | ||||
2017-02-16 | 2017-02-14 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3400 | 7 782 | 3 | 27 280 538 | ||||
2017-01-03 | 2016-12-29 | 4 | Hodges Alastair | UBI | Restricted Shares of Common Stock | D | 3 030 | 2 846 615 | ||||||
2017-01-03 | 2016-12-29 | 4 | Balak Salesh | UBI | Restricted Shares of Common Stock | D | 3 030 | 82 391 | ||||||
2017-01-03 | 2016-12-29 | 4 | Chambers Garry | UBI | Restricted Shares of Common Stock | D | 3 030 | 2 250 594 | ||||||
2017-01-03 | 2016-12-29 | 4 | Oates Adrian | UBI | Restricted Shares of Common Stock | D | 3 030 | 15 170 | ||||||
2016-12-08 | 2016-12-06 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3347 | 16 078 | 5 | 27 272 756 | ||||
2016-12-08 | 2016-12-06 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3347 | 16 078 | 5 | 9 852 756 | ||||
2016-12-05 | 2016-12-05 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3282 | 112 009 | 37 | 27 256 678 | ||||
2016-12-05 | 2016-12-02 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3200 | 165 000 | 53 | 27 144 669 | ||||
2016-12-05 | 2016-12-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3196 | 1 807 004 | 578 | 26 979 669 | ||||
2016-12-05 | 2016-12-02 | 4 | VF Australian Equities Fund | UBI | Common Stock | D | 0,3200 | −154 736 | −50 | 0 | ||||
2016-12-05 | 2016-12-05 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3282 | 112 009 | 37 | 9 836 678 | ||||
2016-12-05 | 2016-12-02 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3200 | 154 736 | 50 | 9 724 669 | ||||
2016-12-05 | 2016-12-02 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3200 | 165 000 | 53 | 9 569 933 | ||||
2016-12-05 | 2016-12-01 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3196 | 1 807 004 | 578 | 9 404 933 | ||||
2016-09-30 | 2016-09-28 | 4 | Hoey David L | UBI | Common Stock | D | 0,2900 | 150 000 | 44 | 350 000 | ||||
2016-07-20 | 3 | VF Australian Equities Fund | UBI | Common Stock | D | 309 472 | ||||||||
2016-07-20 | 3 | VF Australian Equities Fund | UBI | Common Stock | D | 309 472 | ||||||||
2016-07-20 | 3 | VF High Conviction Fund | UBI | Common Stock | D | 15 195 858 | ||||||||
2016-07-20 | 3 | VF High Conviction Fund | UBI | Common Stock | D | 15 195 858 | ||||||||
2016-07-20 | 3 | VF Strategic Equities Fund | UBI | Common Stock | D | 34 840 000 | ||||||||
2016-07-20 | 3 | VF Strategic Equities Fund | UBI | Common Stock | D | 34 840 000 | ||||||||
2016-07-11 | 3 | Coleman Craig E. By partnership | UBI | Common stock, par value US$0.0001 | I | 50 565 330 | ||||||||
2016-07-11 | 3 | Coleman Craig E. By partnership | UBI | Common stock, par value US$0.0001 | I | 50 565 330 | ||||||||
2016-07-11 | 3 | Coleman Craig E. By the Coleman Super Fund | UBI | Common stock, par value US$0.0001 | I | 25 612 665 | ||||||||
2016-07-11 | 3 | Coleman Craig E. By the Coleman Super Fund | UBI | Common stock, par value US$0.0001 | I | 25 612 665 | ||||||||
2016-06-14 | 2016-06-10 | 4 | Hoey David L | UBI | Common Stock | D | 0,2900 | 200 000 | 58 | 200 000 | ||||
2016-02-26 | 2016-02-17 | 4 | Balak Salesh | UBI | Common Stock | D | 2 500 | 79 361 | ||||||
2016-02-26 | 2016-02-17 | 4 | Oates Adrian | UBI | Common Stock | D | 2 500 | 12 140 | ||||||
2016-02-25 | 2016-02-17 | 4 | Hodges Alastair | UBI | Common stock | D | 2 500 | 2 843 585 | ||||||
2016-02-19 | 2016-02-17 | 4 | Chambers Garry | UBI | Common stock | D | 2 500 | 2 247 564 | ||||||
2016-02-19 | 2015-12-16 | 4 | Chambers Garry | UBI | Common stock | D | 0,4500 | −100 000 | −45 | 2 245 064 | ||||
2016-01-14 | 2015-12-31 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,26 | −36 248 | 0 | |||||
2016-01-14 | 2015-12-31 | 4 | Hodges Alastair | UBI | Common Stock | D | 0,2600 | 36 248 | 9 | 2 841 085 | ||||
2016-01-14 | 2015-12-18 | 4 | Hodges Alastair | UBI | Common stock | D | 0,4600 | −30 000 | −14 | 2 804 837 | ||||
2015-07-13 | 2015-07-09 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0,00 | 60 000 | 60 000 | |||||
2015-07-13 | 2015-07-09 | 4 | Wright Paul | UBI | Common stock | D | 4 347 | 7 304 | ||||||
2015-03-02 | 2015-02-20 | 4/A | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 101 819,8200 | 337 428 | 34 356 858 | 337 428 | ||||
2015-03-02 | 2015-02-26 | 4 | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 99 812,5700 | 269 088 | 26 858 365 | 606 516 | ||||
2015-02-24 | 2015-02-20 | 4 | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 101 819,8200 | 337 428 | 34 356 858 | 337 428 | ||||
2015-02-03 | 2015-01-30 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | 40 000 | 40 000 | |||||
2015-02-03 | 2015-01-30 | 4 | Hodges Alastair | UBI | Common Stock | D | 4 347 | 2 834 837 | ||||||
2015-02-03 | 2015-01-30 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,00 | 40 000 | 40 000 | |||||
2015-02-03 | 2015-01-30 | 4 | Chambers Garry | UBI | Common Stock | D | 4 347 | 2 345 064 | ||||||
2015-02-03 | 2015-01-30 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | 40 000 | 40 000 | |||||
2015-02-03 | 2015-01-30 | 4 | Oates Adrian | UBI | Common Stock | D | 4 347 | 9 640 | ||||||
2015-02-03 | 2015-01-30 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | 40 000 | 40 000 | |||||
2015-02-03 | 2015-01-30 | 4 | Balak Salesh | UBI | Common Stock | D | 4 347 | 76 861 | ||||||
2014-06-13 | 2014-06-12 | 4 | Wright Paul | UBI | Common stock | D | 2 040 | 2 957 | ||||||
2014-06-13 | 2013-12-12 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0,00 | 60 000 | 60 000 | |||||
2014-05-16 | 2014-05-15 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 7 670,0000 | 50 000 | 383 500 | 2 886 340 | ||||
2014-05-16 | 2014-05-14 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 8 940,0000 | 50 000 | 447 000 | 2 836 340 | ||||
2014-05-14 | 2014-05-14 | 4 | Hanley Denis | UBI | Common Stock | D | 8 127,9000 | 50 000 | 406 395 | 1 918 002 | ||||
2014-05-13 | 2014-05-13 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 11 500,0000 | 50 000 | 575 000 | 2 786 340 | ||||
2014-05-13 | 2014-05-12 | 4 | DENVER ANDREW By wife | UBI | Common Stock | I | 6 610,5000 | 30 000 | 198 315 | 90 797 | ||||
2014-05-08 | 2014-05-06 | 4 | Smith Christopher M | UBI | Common Stock | D | 11 249,9500 | 30 000 | 337 498 | 30 000 | ||||
2014-04-16 | 2014-04-14 | 4 | Wright Paul By Macquarie Super Manager | UBI | Common Stock | I | 56 567,0800 | 142 105 | 8 038 465 | 186 771 | ||||
2014-01-08 | 2013-12-12 | 4 | Davis Frederick Harry | UBI | Stock Option (Right to Buy) | D | 0,00 | 40 000 | 40 000 | |||||
2014-01-08 | 2013-12-12 | 4 | Davis Frederick Harry | UBI | Common Stock | D | 2 040 | 2 957 | ||||||
2014-01-06 | 2013-12-24 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,22 | −384 224 | 0 | |||||
2014-01-06 | 2013-12-24 | 4 | Hodges Alastair | UBI | Common Stock | D | 0,2200 | 384 224 | 85 | 2 830 490 | ||||
2014-01-06 | 2013-12-12 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | 40 000 | 40 000 | |||||
2014-01-06 | 2013-12-12 | 4 | Hodges Alastair | UBI | Common Stock | D | 2 040 | 2 446 266 | ||||||
2014-01-06 | 2013-12-12 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | 40 000 | 40 000 | |||||
2014-01-06 | 2013-12-12 | 4 | Balak Salesh | UBI | Common Stock | D | 2 040 | 72 514 | ||||||
2014-01-06 | 2013-12-24 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,22 | −288 168 | 0 | |||||
2014-01-06 | 2013-12-24 | 4 | Chambers Garry | UBI | Common Stock | D | 0,2200 | 288 168 | 63 | 2 340 717 | ||||
2014-01-06 | 2013-12-12 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,00 | 40 000 | 40 000 | |||||
2014-01-06 | 2013-12-12 | 4 | Chambers Garry | UBI | Common Stock | D | 2 040 | 2 052 549 | ||||||
2014-01-06 | 2013-12-12 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | 40 000 | 40 000 | |||||
2014-01-06 | 2013-12-12 | 4 | Oates Adrian | UBI | Common Stock | D | 2 040 | 5 293 | ||||||
2013-10-09 | 2013-09-26 | 4 | Heinberg Marshall | UBI | Common Stock | D | 20 000 | 20 000 | ||||||
2013-10-04 | 2013-09-26 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Allison Denver | UBI | Common Stock | I | 200 000 | 2 736 340 | ||||||
2013-10-04 | 2013-09-26 | 4 | DENVER ANDREW | UBI | Common Stock | D | 28 000 | 437 050 | ||||||
2013-10-04 | 2013-09-26 | 4 | Hanley Denis Denis Hanley Superannuation Fund Pty Ltd | UBI | Common Stock | I | 200 000 | 954 105 | ||||||
2013-10-04 | 2013-09-26 | 4 | Hanley Denis Denis M Hanley Pty Ltd | UBI | Common Stock | I | 6 000 | 54 889 | ||||||
2013-10-04 | 2013-09-26 | 4 | Hanley Denis | UBI | Common Stock | D | 29 772 | 1 868 002 | ||||||
2013-06-11 | 2013-06-11 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,22 | −384 224 | 384 224 | |||||
2013-06-11 | 2013-06-11 | 4 | Hodges Alastair | UBI | Common Stock | D | 84 529,2800 | 384 224 | 32 478 178 | 2 444 226 | ||||
2013-06-11 | 2013-06-11 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,22 | −288 168 | 288 168 | |||||
2013-06-11 | 2013-06-11 | 4 | Chambers Garry | UBI | Common Stock | D | 63 396,9600 | 288 168 | 18 268 975 | 2 050 509 | ||||
2013-05-28 | 2013-05-27 | 4 | Wright Paul | UBI | Common Stock | D | 917 | 917 | ||||||
2013-05-28 | 2012-11-13 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0,00 | 37 500 | 37 500 | |||||
2013-02-20 | 2013-02-12 | 4 | Oates Adrian | UBI | Common Stock | D | 7 291,3800 | −8 333 | −60 759 | 3 253 | ||||
2013-01-08 | 2012-05-16 | 4 | DENVER ANDREW | UBI | Common Stock | I | 378 645,6800 | 676 153 | 256 022 412 | 2 536 340 | ||||
2013-01-08 | 2012-05-16 | 4 | DENVER ANDREW By spouse | UBI | Common Stock | I | 378 645,6800 | −676 153 | −256 022 412 | 60 797 | ||||
2013-01-08 | 2012-05-15 | 4 | DENVER ANDREW | UBI | Common Stock | I | 379 890,0000 | 678 375 | 257 707 879 | 1 860 187 | ||||
2013-01-08 | 2012-05-15 | 4 | DENVER ANDREW | UBI | Common Stock | D | 379 890,0000 | −678 375 | −257 707 879 | 409 050 | ||||
2012-12-28 | 2012-12-18 | 4 | Wilson Elizabeth | UBI | Common Stock | I | 3 999,6000 | 4 444 | 17 774 | 2 035 944 | ||||
2012-12-28 | 2012-12-19 | 4 | Balak Salesh | UBI | Common Stock | D | 1 999,8000 | 2 222 | 4 444 | 70 474 | ||||
2012-12-28 | 2012-12-18 | 4 | Wright Paul By Macquarie Super Manager | UBI | Common Stock | I | 14 999,4000 | 16 666 | 249 980 | 44 666 | ||||
2012-11-23 | 2012-11-13 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | 25 000 | 25 000 | |||||
2012-11-23 | 2012-11-13 | 4 | Hodges Alastair | UBI | Common Stock | D | 917 | 2 060 002 | ||||||
2012-11-23 | 2012-11-13 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | 25 000 | 25 000 | |||||
2012-11-23 | 2012-11-13 | 4 | Oates Adrian | UBI | Common Stock | D | 917 | 11 586 | ||||||
2012-11-23 | 2012-11-13 | 4 | Davis Frederick Harry | UBI | Stock Option (Right to Buy) | D | 0,00 | 25 000 | 25 000 | |||||
2012-11-23 | 2012-11-13 | 4 | Davis Frederick Harry | UBI | Common Stock | D | 917 | 917 | ||||||
2012-11-21 | 2012-11-13 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | 25 000 | 25 000 | |||||
2012-11-21 | 2012-11-13 | 4 | Balak Salesh | UBI | Common Stock | D | 917 | 68 252 | ||||||
2012-11-21 | 2012-11-13 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,00 | 25 000 | 25 000 | |||||
2012-11-21 | 2012-11-13 | 4 | Chambers Garry | UBI | Common Stock | D | 917 | 1 762 341 | ||||||
2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | −8 333 | 0 | |||||
2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | −8 333 | 0 | |||||
2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | −21 666 | 73 334 | |||||
2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Common Stock | D | 38 332 | 67 335 | ||||||
2012-08-27 | 2012-08-23 | 4 | Davis Frederick Harry By wife | UBI | Common Stock | I | 0,7000 | 23 376 | 16 | 28 747 | ||||
2012-08-27 | 2012-08-22 | 4 | Davis Frederick Harry By wife | UBI | Common Stock | I | 0,7000 | 5 371 | 4 | 5 371 | ||||
2012-03-06 | 2012-02-27 | 4 | Hodges Alastair | UBI | Common Stock | D | 0,7300 | −1 000 000 | −730 | 2 059 085 | ||||
2012-01-24 | 2011-03-07 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | −25 000 | −36 | 17 431 617 | ||||
2012-01-24 | 2011-03-04 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | −24 000 | −34 | 17 456 617 | ||||
2012-01-24 | 2011-03-03 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | −10 000 | −14 | 17 480 617 | ||||
2012-01-24 | 2011-03-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | −34 | −0 | 17 490 617 | ||||
2012-01-24 | 2011-02-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | −1 083 | −2 | 17 490 651 | ||||
2012-01-24 | 2011-02-25 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | −2 590 | −4 | 17 491 734 | ||||
2012-01-24 | 2011-02-23 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | −37 279 | −57 | 17 494 324 | ||||
2012-01-24 | 2011-02-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | −5 000 | −7 | 17 531 603 | ||||
2012-01-24 | 2011-02-17 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3500 | −5 000 | −7 | 17 536 603 | ||||
2012-01-24 | 2011-02-16 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | −5 000 | −7 | 17 541 603 | ||||
2012-01-24 | 2011-02-15 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | −5 000 | −7 | 17 546 603 | ||||
2012-01-24 | 2011-02-11 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3800 | −22 463 | −31 | 17 551 603 | ||||
2012-01-24 | 2011-02-09 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | −22 | −0 | 17 574 066 | ||||
2012-01-24 | 2011-02-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3700 | −10 000 | −14 | 17 574 088 | ||||
2012-01-24 | 2011-02-07 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3800 | −50 000 | −69 | 17 584 088 | ||||
2012-01-24 | 2011-02-02 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5300 | −50 000 | −76 | 17 589 088 | ||||
2012-01-24 | 2011-02-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | −50 000 | −76 | 17 639 088 | ||||
2012-01-24 | 2011-01-31 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5000 | −50 000 | −75 | 17 689 088 | ||||
2012-01-24 | 2011-01-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | −50 000 | −76 | 17 739 088 | ||||
2012-01-24 | 2011-01-27 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | −17 869 | −27 | 17 789 088 | ||||
2012-01-24 | 2011-01-25 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | −73 | −0 | 17 806 957 | ||||
2012-01-24 | 2011-01-24 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | −50 000 | −76 | 17 807 030 | ||||
2012-01-24 | 2011-01-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | −50 000 | −76 | 17 857 030 | ||||
2012-01-24 | 2011-01-20 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | −50 000 | −76 | 17 907 030 | ||||
2012-01-24 | 2011-01-19 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | −50 000 | −76 | 17 957 030 | ||||
2012-01-24 | 2011-01-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | −50 000 | −76 | 18 007 030 | ||||
2012-01-24 | 2011-01-14 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4800 | −50 000 | −74 | 18 057 030 | ||||
2012-01-24 | 2011-01-13 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5000 | −50 000 | −75 | 18 107 038 | ||||
2012-01-24 | 2011-01-12 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4900 | −50 000 | −74 | 18 157 030 | ||||
2012-01-24 | 2011-09-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 0,9600 | −1 500 000 | −1 440 | 15 749 937 | ||||
2012-01-24 | 2011-08-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,1900 | −752 | −1 | 17 249 937 | ||||
2012-01-24 | 2011-07-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3000 | −341 | −0 | 17 250 689 | ||||
2012-01-24 | 2011-04-29 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5300 | −10 000 | −15 | 17 251 030 | ||||
2012-01-24 | 2011-04-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | −10 000 | −15 | 17 261 030 | ||||
2012-01-24 | 2011-04-27 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | −10 000 | −15 | 17 271 030 | ||||
2012-01-24 | 2011-04-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4900 | −35 000 | −52 | 17 281 030 | ||||
2012-01-24 | 2011-04-20 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4400 | −10 000 | −14 | 17 316 030 | ||||
2012-01-24 | 2011-04-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | −8 000 | −11 | 17 326 030 | ||||
2012-01-24 | 2011-04-15 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | −7 500 | −11 | 17 334 030 | ||||
2012-01-24 | 2011-04-14 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4100 | −10 000 | −14 | 17 341 530 | ||||
2012-01-24 | 2011-03-30 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3900 | −155 | −0 | 17 351 530 | ||||
2012-01-24 | 2011-03-29 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3800 | −32 | −0 | 17 351 685 | ||||
2012-01-24 | 2011-03-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | −4 900 | −7 | 17 351 717 | ||||
2012-01-24 | 2011-03-10 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4000 | −25 000 | −35 | 17 356 617 | ||||
2012-01-24 | 2011-03-09 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | −25 000 | −36 | 17 381 617 | ||||
2012-01-24 | 2011-03-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4100 | −25 000 | −35 | 17 406 617 |